As of 2026-09-11 · the last 10 years
Research intensity has climbed to about 99% of the element's own all-time peak, with the peak year (2026) falling inside this window.
Research intensity ran from about 21% of the element's own all-time peak in 2016 to about 99% in 2026 — a net rise with setbacks along the way, and the all-time peak (2026) falls inside this window. This trajectory represents an uneven climb, where attention has grown significantly despite fluctuations in the yearly data. Among the 118 elements, moscovium has one of the smaller research literatures of any element.
The number of papers involving the element rose from about 10 in 2016 to about 18 in 2025 (1.8x). That is slower than the literature as a whole grew over the same years, so the element lost ground in the wider body of research even as its own count rose.
The research landscape is dominated by a single community: Synthesis and Decay of Superheavy Elements and Heavy-Ion Collision Physics. This group focuses on the creation and behavior of superheavy nuclei, with distinctive work on element synthesis, sequential fission, and synthesis reactions. Moscovium is a minor presence in this much larger community, with under 1% of its papers involving moscovium. However, it accounts for about 93% of moscovium’s recent research, a share that has risen from about 67% in the previous period. Key work includes a 2024 study on relativistic effects in chemical properties, cited about 19 times, and a 2023 paper on colliding heavy nuclei, cited about 25 times.
A smaller but growing area is Computational Materials Science: Electronic Structure, Phase Transitions and Machine Learning Potentials. Here, moscovium is also a minor presence, with under 1% of community papers involving it, yet it now holds about 7% of the element's recent research, up from 0% previously. An anchor paper from 2025 on Group 15 elements has not yet been cited.
Several other communities show declining or steady shares. Actinide Chemistry and Nuclear Fuel Materials, where moscovium is a minor presence, saw its share drop from about 20% to 0%. Radioligand Therapy and Nuclear Imaging for Prostate, Thyroid, and Neuroendocrine Cancers, and Hyperpolarized Xenon MRI and Gas Spectroscopy for Lung and Brain Imaging, both saw their shares fall from about 7% to 0%. Stable Isotope Geochemistry of Marine Sediments and Paleoenvironments remained steady at 0%.
Overall, moscovium’s research is consolidating around the synthesis and decay of superheavy elements, while its presence in broader materials science and nuclear chemistry communities has diminished or vanished. The element’s literature remains small, but its intensity relative to its own history is at a historic high.
For a deeper look at moscovium’s current standing, see the Last 12 Months and Executive Brief reports.
What changed in the past year: new papers, shifting applications, emerging collaborators. See the momentum over a shorter window than the decade view.
Personal →See recent trends — Personal.
A by-topic status read of what changed and what's new — built for decision-makers, not search engines. Citation clusters, emerging applications, and the papers that matter most.
Professional →See the executive read — Professional.
These are the nine that matter most. There are more — browse all of them free.
Found one worth keeping? A free account remembers it for you, so you're not re-finding it every visit.
Showing Moscovium's three strongest connections. Personal opens the slider and the whole 118-element graph.